Healthcare -
Biotechnology - NASDAQ - US
$ 15.04
-3.16 %
$ 1.19 B
Market Cap
-3.48
P/E
VRDN - COST OF REVENUE
Cost of Revenue VRDN - Viridian Therapeutics, Inc.
1.32 M
LAST VALUE
46.02%
2 YEAR CAGR
-46.59%
5 YEAR CAGR
-6.17%
10 YEAR CAGR